Page 14 - Compass Pathways News Today

TUESDAY, Aug. 1, 2023 (HealthDay News) -- One dose of the hallucinogenic ingredient in "magic mushrooms" may help some people with anorexia move past their preoccupation with body image, an

The paradox of techno-optimism by embattled tech CEOs and prominent figures of psychiatry at a huge conference on the future of mental health.

CMPS earnings call for the period ending June 30, 2023.

In July, Australia became the first country to legalize the psychedelics drugs psilocybin and MDMA as mental health treatments. This week, we’re revisiting an episode on the opportunities — and challenges — of bringing psychedelics to market.

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.

TUESDAY, Aug. 1, 2023 (HealthDay News) -- One dose of the hallucinogenic ingredient in "magic mushrooms" may help some people with anorexia move past their preoccupation with body image, an

COMPASS Pathways (NASDAQ:CMPS – Get Free Report) will be releasing its earnings data before the market opens on Thursday, August 3rd. Analysts expect COMPASS Pathways to post earnings of ($0.69) per share for the quarter. Parties interested in listening to the company’s conference call can do so using this link. COMPASS Pathways (NASDAQ:CMPS – Get […]

TUESDAY, Aug. 1, 2023 (HealthDay News) -- One dose of the hallucinogenic ingredient in "magic mushrooms" may help some people with anorexia move past their preoccupation with body image, an

TUESDAY, Aug. 1, 2023 (HealthDay News) -- One dose of the hallucinogenic ingredient in "magic mushrooms" may help some people with anorexia move past their preoccupation with body image, an

TUESDAY, Aug. 1, 2023 (HealthDay News) -- One dose of the hallucinogenic ingredient in "magic mushrooms" may help some people with anorexia move past their preoccupation with body image, an